The emergency use authorization of a third vaccine against COVID-19 in the United States today, just over a year since the virus was identified, demonstrates extraordinary scientific commitment and progress.
The emergency use authorization of a third vaccine against COVID-19 in the United States today, just over a year since the virus was identified, demonstrates extraordinary scientific commitment and progress.
New CDC findings further confirm that wearing a well-fitting mask can significantly reduce the risk of coronavirus infection. CDC offers tips for improving mask fit; for some individuals, double-masking may be helpful to improve fit, but it is not necessary for all.
As the U.S. health care system grapples with unrelenting increases in COVID-19 cases during a pandemic that has claimed the lives of more than 400,000 Americans, IDSA and the CDC have extended their partnership to equip frontline health care professionals with the latest information on fighting the disease.
Antibiotic resistance could be the next epidemic to highlight the impacts of structural racism on health and access to health services, caution the authors of an analysis published in Nature Medicine Monday. The article argues that stronger measures to combat antibiotic resistance should be a key component of broader efforts to promote health equity.
President Biden’s executive orders and national strategy to contain the COVID-19 pandemic, along with renewed participation in the World Health Organization, offer a comprehensive approach with tremendous promise toward ending the nation’s public health crisis.
The Infectious Diseases Society of America and its HIV Medicine Association strongly endorse the executive order signed by President Biden today requiring face masks on federal property and other areas of federal authority for the next 100 days to prevent the spread of COVID-19.
The Infectious Diseases Society of America and its HIV Medicine Association strongly support the incoming Administration’s request for $400 billion to strengthen our pandemic response and safely reopen schools.
Plans to significantly accelerate COVID-19 vaccine rollout announced by the Department of Health and Human Services today represent an important step toward controlling the pandemic.
Ten researchers who are exploring the link between an infectious agent and Alzheimer’s disease have each been awarded $100,000 research grants through the IDSA Foundation’s Microbial Pathogenesis in Alzheimer’s Disease Grant program
The HIV Medicine Association is pleased to announce the special appointment of Marwan Haddad, MD, MPH, as chair-elect. Dr. Haddad served on the HIVMA Board of Directors from October 2017 to October 2020 and is medical director of the Center for Key Populations for Community Health Center, Inc.
The current obstacles to swift and widespread COVID-19 vaccine access are impeding control of the pandemic amid soaring rates of infections, illnesses, hospitalizations and deaths and must be addressed effectively and immediately.
The bipartisan bill passed by the House and the Senate and signed by the president provides urgently needed resources to confront COVID-19, funds critical programs across the government in 2021 and offers great hope for recovery from some of the pandemic’s damaging impacts in the year to come.